US STOCK
OSCR Stock Analysis
US stocks · market data · technical indicators
Oscar Health, Inc.
OSCRUS stocksQuote delayed 15 min
9/11 上午11:14 updated
$32.58
+0.82+2.58%
Open
$31.75
High
$33.47
Low
$31.38
Volume
410.72萬
OSCR price history
+10.03%Open
29.61
Latest
32.58
High
33.01
Low
29.61
Average
31.35
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score85
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
BuyCurrent Price$32.58
Target Price$43.983
Change %+2.58%
Institutional
Net Buying
Foreign Ownership
Reducing
Market Heat
Positive
Fundamentals (US)
P/E Ratio
25.78x
ROE
34.26%
P/B Ratio
5.04x
Dividend Yield
--
Market Insight
The composite score points to a strong buy signal (85/100), with several technical and fundamental indicators in positive territory. Return on equity of 34.26% indicates solid profitability. The target price implies roughly 35.00% upside.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
OSCR - Oscar Health, Inc.
EPS
1.30USD
Forward EPS
1.88USD
P/E
25.78x
Forward P/E
17.81x
P/B
5.04x
ROE
34.26%
ROA
4.47%
Operating margin
7.96%
Profit margin
3.60%
Revenue growth
70.40%
Earnings growth
--
Dividend yield
--
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B |
| Net income | $361.81M | $679.00M | -$352.61M | -$137.45M | -$228.36M |
| Basic EPS | 1.20 | 2.28 | -1.24 | -0.53 | -0.89 |
| Diluted EPS | 1.10 | 2.07 | -1.24 | -0.53 | -0.89 |
Estimates vs actuals
Next earnings
2026-11-09
EPS estimate
-0.25
Revenue estimate
$4.73B
Last surprise
+189.17%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-09 | -0.25 | Not reported | — |
| 2026-08-06 | 0.38 | 1.10 | +189.17% |
| 2026-05-06 | 1.10 | 2.07 | +88.18% |
| 2026-02-10 | -0.92 | -1.24 | -34.58% |
| 2025-11-06 | -0.58 | -0.53 | +8.65% |
| 2025-08-06 | -0.84 | -0.89 | -6.46% |
| 2025-05-07 | 0.81 | 0.92 | +13.93% |
| 2025-02-04 | -0.58 | -0.62 | -6.49% |
| 2024-11-07 | -0.18 | -0.22 | -25.04% |
| 2024-08-07 | 0.16 | 0.20 | +29.03% |
| 2024-05-07 | 0.27 | 0.62 | +129.63% |
| 2024-02-07 | -0.70 | -0.66 | +6.38% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $297.5M | 0.00% |
| BlackRock Inc. | 2024-06-30 | $224.2M | 0.01% |
| STATE STREET CORP | 2026-06-30 | $165.5M | 0.00% |
| CITADEL ADVISORS LLC | 2026-06-30 | $120.6M | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $115.1M | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $93.7M | 0.13% |
| Bridgewater Associates, LP | 2026-06-30 | $6.1M | 0.03% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$30.40
Target range
$25.00 – $39.00
Implied upside
-9.31%
Strong buy
3
Buy
0
Hold
7
Sell
0
Strong sell
1
Advertisement